Alexander Zverev booked a third straight Australian Open semifinal on Tuesday, outlasting Learner Tien 6-3, 6-7(5), 6-1, ...

Afrezza is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus.

MannKind Corporation (NASDAQ:MNKD) shares gained 3.5% on Monday after the company said the U.S. Food and Drug Administration ...

Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...

For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation ...

For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation in the digestive tract and the absence of a dedicated intestinal transport ...

Researchers from Kumamoto University have developed a new peptide-based technology that enables insulin—normally injected—to be taken orally while still powerfully lowering blood sugar. Their ...

Inhaled insulin works quickly at meals and may reduce injections for some adults with diabetes.

A wearable device pairs glucose-responsive insulin with algorithmic pump control, creating dual safety loops that reduced ...

Diabetes is becoming increasingly common in our communities, and is affecting people at surprisingly younger ages. Nationally, about 38.4 million Americans (approximately 1 in 10) were living with dia ...

Delaware is the latest state to accuse pharmaceutical manufactures of jacking up insulin prices, even as the cost to produce diabetes medications has decreased.

“For decades, the diabetes world has focused on lowering sugar, not on treating the root cause of the disease nor on stopping its progression” said Dr. Dror Chevion, co-founder and CEO of Concenter ...